Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long Term Extension Study in Patients With Primary Hyperoxaluria (PHYOX3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04042402
Recruitment Status : Enrolling by invitation
First Posted : August 2, 2019
Last Update Posted : July 16, 2021
Sponsor:
Information provided by (Responsible Party):
Dicerna Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2023